Genetic discrimination legislation in Canada: moving from rhetoric to real debate

Affiliations

¹ Children's Hospital of Eastern Ontario Research Institute (Nicholls); School of Epidemiology, Public Health and Preventive Medicine (Nicholls), University of Ottawa; Graduate School of Public and International Affairs (Fafard), Institute for Science, Society and Policy (Fafard), and Centre for Health Law, Policy and Ethics (Fafard), University of Ottawa, Ottawa, Ont. snicholls@cheo.on.ca.
² Children's Hospital of Eastern Ontario Research Institute (Nicholls); School of Epidemiology, Public Health and Preventive Medicine (Nicholls), University of Ottawa; Graduate School of Public and International Affairs (Fafard), Institute for Science, Society and Policy (Fafard), and Centre for Health Law, Policy and Ethics (Fafard), University of Ottawa, Ottawa, Ont.

Stuart G Nicholls et al. CMAJ. 2016.

. 2016 Aug 9;188(11):788-789.

doi: 10.1503/cmaj.151170. Epub 2016 Feb 8.

¹ Children's Hospital of Eastern Ontario Research Institute (Nicholls); School of Epidemiology, Public Health and Preventive Medicine (Nicholls), University of Ottawa; Graduate School of Public and International Affairs (Fafard), Institute for Science, Society and Policy (Fafard), and Centre for Health Law, Policy and Ethics (Fafard), University of Ottawa, Ottawa, Ont. snicholls@cheo.on.ca.
² Children's Hospital of Eastern Ontario Research Institute (Nicholls); School of Epidemiology, Public Health and Preventive Medicine (Nicholls), University of Ottawa; Graduate School of Public and International Affairs (Fafard), Institute for Science, Society and Policy (Fafard), and Centre for Health Law, Policy and Ethics (Fafard), University of Ottawa, Ottawa, Ont.

No abstract available

Cited by

Attitudes to incorporating genomic risk assessments into population screening programs: the importance of purpose, context and deliberation.
Nicholls SG, Etchegary H, Carroll JC, Castle D, Lemyre L, Potter BK, Craigie S, Wilson BJ; CIHR Emerging Team in Genomics and Screening. Nicholls SG, et al. BMC Med Genomics. 2016 May 23;9(1):25. doi: 10.1186/s12920-016-0186-5. BMC Med Genomics. 2016. PMID: 27215612 Free PMC article.

1. Joly Y, Ngueng Feze I, Simard J. Genetic discrimination and life insurance: a systematic review of the evidence. BMC Med 2013;11:25. - PMC - PubMed
1. Green MJ, Botkin JR. “Genetic exceptionalism” in medicine: clarifying the differences between genetic and nongenetic tests”. Ann Intern Med 2003;138:571–5. - PubMed
1. Nicholls SG, Joly Y, Moher E, et al. Genetic discrimination and insurance in Canada: Where are we now? Risk 2014;30:46–52.
1. Van Hoyweghen I, Rebert L. Your genes in insurance: from genetic discrimination to genomic solidarity. Personalized Med 2012;9:871–7. - PubMed
1. Joly Y, Burton H, Knoppers BM, et al. Life insurance: genomic stratification and risk classification. Eur J Hum Genet 2014; 22:575–9. - PMC - PubMed